Genomic analysis identifies new drivers and progression pathways in skin basal cell carcinomaXimena Bonilla, Sergey I. Nikolaev, Federico Santoni et al.|Nature Genetics|2016Cited by 495
LRP8‐mediated selenocysteine uptake is a targetable vulnerability in MYCN‐amplified neuroblastomaHamed Alborzinia, José Pedro Friedmann Angeli, Zhiyi Chen et al.|EMBO Molecular Medicine|2023Cited by 75
Drugging the “Undruggable” MYCN Oncogenic Transcription Factor: Overcoming Previous Obstacles to Impact Childhood CancersAdam J. Wolpaw, Yaël P. Mossé, Richard Bayliss et al.|Cancer Research|2021Cited by 70
USP28 controls SREBP2 and the mevalonate pathway to drive tumour growth in squamous cancerCarina R. Maier, Almut Schulze, Oliver Hartmann et al.|Cell Death and Differentiation|2023Cited by 34